Join Now

Category Archives: BioUtah News

NUSANO TO PRESENT AT JEFFERIES RADIOPHARMA INNOVATION SUMMIT

VALENCIA, Calif. – April 10, 2024 – Nusano, a physics company transforming the production of medical radioisotopes, today announced it will attend and present at Jefferies Radiopharma Innovation Summit in New York City on Thursday, April 11, 2024. In his presentation, Nusano CEO Chris Lowe will provide an update on the company’s commercialization plans, including […]

| Comments Off on NUSANO TO PRESENT AT JEFFERIES RADIOPHARMA INNOVATION SUMMIT

Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing

Fewer patients were prescribed medications with gene-drug interactions after taking the GeneSight test SALT LAKE CITY, April 09, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, revealed results from a multi-year, real-world study of nearly 21,000 patients that indicated those with major depressive disorder had reduced […]

| Comments Off on Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing

Renalytix Announces Financing with Expected Size of up to $4 Million

LONDON and SALT LAKE CITY, April 08, 2024 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces a registered direct offering of ordinary shares at a purchase price equivalent to $0.75 per NASDAQ ADS ($0.375 per common stock share) (£0.0025 each) (the “Ordinary Shares”) (the “Fundraise”) to DB Capital Partners Healthcare, L.P. (the “Purchaser”), […]

| Comments Off on Renalytix Announces Financing with Expected Size of up to $4 Million

BD Named a Best Employer for Excellence in Employee Well-Being

FRANKLIN LAKES, N.J., April 9, 2024 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will receive the Business Group on Health “Best Employers: Excellence in Health & Well-being Award” for its commitment to advancing employee well-being through comprehensive and innovative benefits and initiatives. BD also […]

| Comments Off on BD Named a Best Employer for Excellence in Employee Well-Being

STUDY OF NFL ALUMNI COHORT FINDS MAJORITY SUFFER FROM HEART DISEASE WITHOUT KNOWING IT

ATLANTA–(BUSINESS WIRE)– Edwards Lifesciences (NYSE: EW) announced the release of data from the HUDDLE study that examined the prevalence of heart disease and associated risk factors among members of the National Football League (NFL) Alumni Association and their families. The findings of this study, which identified a significant discrepancy between participant self-awareness and actual prevalence […]

| Comments Off on STUDY OF NFL ALUMNI COHORT FINDS MAJORITY SUFFER FROM HEART DISEASE WITHOUT KNOWING IT

Leash Biosciences Announces $9.3 Million Seed Financing to Pioneer AI-Driven Medicinal Chemistry

– Financing will support development of a foundational machine learning model of medicinal chemistry that can accurately predict small molecule drug candidates for any protein – – Releases unprecedented dataset publicly to address critical challenges in drug discovery with machine learning – SALT LAKE CITY, April 05, 2024 (GLOBE NEWSWIRE) — Leash Biosciences, an artificial […]

| Comments Off on Leash Biosciences Announces $9.3 Million Seed Financing to Pioneer AI-Driven Medicinal Chemistry

BioTech Nation Podcast: Fighting Inflammation, and Alzheimer’s: Dr. David Bearss, President & CEO Halia Therapeutics

BioTech Nation Podcast: Fighting Inflammation, and Alzheimer’s: Dr. David Bearss, President & CEO Halia Therapeutics

| Tagged | Comments Off on BioTech Nation Podcast: Fighting Inflammation, and Alzheimer’s: Dr. David Bearss, President & CEO Halia Therapeutics

Jennifer Arnold, COO of Transit Scientific, promoted to President & CEO

Jennifer Arnold, COO of Transit Scientific, promoted to President & CEO

| Tagged | Comments Off on Jennifer Arnold, COO of Transit Scientific, promoted to President & CEO

CancerVax Launches $5 Million Funding Round

Proceeds from the SEC qualified Reg A+ offering will allow the Company to continue work on its breakthrough cancer treatments

| Tagged | Comments Off on CancerVax Launches $5 Million Funding Round

New ARUP University Business Unit Focuses on Patients and Services at University of Utah Health

Dan Albertson, MD, will serve as president of the University Business Unit.

| Tagged | Comments Off on New ARUP University Business Unit Focuses on Patients and Services at University of Utah Health

VAREX ANNOUNCES CLOSING OF REVOLVING CREDIT FACILITY OF $155 MILLION

Varex Imaging has entered into a senior secured revolving credit agreement for an initial aggregate principal amount of up to $155 million.

| Tagged | Comments Off on VAREX ANNOUNCES CLOSING OF REVOLVING CREDIT FACILITY OF $155 MILLION

New Survey Reveals Patients Receive Too Many Needlesticks

Most Americans Unaware of Challenges from Common Hospital Procedures

| Tagged | Comments Off on New Survey Reveals Patients Receive Too Many Needlesticks